The implications of antigenic diversity for vaccine development.

The implications of antigenic diversity for vaccine development.

Item
http://www.wikidata.org/entity/Q33593828
Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes.Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaquesMapping the immune response to the outer domain of a human immunodeficiency virus-1 clade C gp120Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity.Antigen retrieval to improve the immunocytochemistry detection of sigma-1 receptors and ER chaperones.Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients.
P2860

The implications of antigenic diversity for vaccine development.

Item
http://www.wikidata.org/entity/Q33593828
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The implications of antigenic diversity for vaccine development.
@ast
The implications of antigenic diversity for vaccine development.
@en
type
label
The implications of antigenic diversity for vaccine development.
@ast
The implications of antigenic diversity for vaccine development.
@en
prefLabel
The implications of antigenic diversity for vaccine development.
@ast
The implications of antigenic diversity for vaccine development.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
The implications of antigenic diversity for vaccine development.
@en
P2093
P304
P31
P356
10.1016/S0165-2478(98)00176-X
P433
P478
P577
P698